33 results about "Ethyl nicotinate" patented technology

The invention relates to a method for synthesizing an important intermediate 2-chloro-3-amino-4-methylpyridine for an anti-AIDS medicament Nevirapine, and belongs to the technical field of organic synthesis. The method comprises the following process steps that: ethyl cyanoacetate and acetone are dehydrated and condensed to generate a condensation compound I under the action of a catalyst; dimethyl formamide, dimethyl sulfate and sodium methoxide solution react to generate N,N-dimethylformamiade dimethyl acetal (N,N-dimethyl formamide A), and then the N,N-dimethylformamiade dimethyl acetal reacts with the condensation compound I to generate conjugated enamine, namely a condensation compound II; the condensation compound II is cyclized by hydrochloric acid and ethanol to form a cyclic compound 2-chloro-4-methyl-ethyl nicotinate; the 2-chloro-4-methyl-ethyl nicotinate is ammonolyzed by ammonia gas to form 2-chloro-4-methyl-niacinamide; and the 2-chloro-4-methyl-niacinamide is subjected to Hofmann degradation reaction to form the 2-chloro-3-amino-4-methylpyridine. Compared with the prior synthesizing method, the method of the invention has the remarkable characteristic of reducing the reaction steps, and is suitable for large-scale industrialized production; the molar total yield of the five-step reaction is improved to 27 percent from the prior 24 percent; and the purity of the product reaches over 99 percent.

The invention provides a process preparation method of beta-nicotinamide mononucleotide. With tetraacetylribose and niacinamide or ethyl nicotinate as starting materials, through main process steps ofcondensation, ammonolysis, chemical resolution, phosphorylation and the like, and through optimization of the process method, the beta-nicotinamide mononucleotide is prepared; the method is based onthe purposes of quality control and safety of the beta-nicotinamide mononucleotide, industrial batch production feasibility of a preparation process and the like; the preparation method is improved onthe basis of an original process route, optimizes the selected materials and reagents, controls the material amount and the like, and has the advantages of simplicity in operation, easiness in process amplification, higher yield, controllable final product quality, controllable safety and the like compared with the original preparation process.

The present invention relates to a method of preparing racemic nicotine comprising: (i) reacting ethyl nicotinate and N-vinylpyrrolidone in the presence of an alcoholate base to 3-nicotinoyl-1-vinylpyrrolidin-2-one; (ii) reacting the 3-nicotinoyl-1-vinylpyrrolidin-2-one with an acid to myosmine; (iii) reducing the myosmine to nornicotine using a reducing agent; and (iv) methylating the nornicotine to obtain the racemic nicotine.

The invention discloses high-penetration slimming camellia japonica massage oil, which is prepared by evenly mixing the following ingredients in parts by mass: 70 to 80 parts of micromolecule camellia japonica massage oil, 5 to 10 parts of candlenut nut oil, 3 to 5 parts of evening primrose seed oil, 3 to 5 parts of black pepper essential oil, 2 to 5 parts of hops oil, 2 to 5 parts of shaddock oil, 0.5 to 1 part of ethyl nicotinate, 0.1 to 0.3 part of capsicum oleoresin, 0.1 to 0.3 part of rosemary extract and 0.1 to 0.3 part of tea polyphenol or aliphatic ester of the tea polyphenol. The camellia japonica massage oil has no obvious greasy feeling, can effectively permeate to subcutaneous fat from skin, promotes internal circulation of blood and cells, dredges blood vessels, drains toxin and drains fat metabolite out of a body.

The invention provides a preparation method of 3, 4, 5-trimethylhydroquinone dialkanoate. The preparation method comprises the following steps: reacting in the presence of a catalyst and a cocatalystand carrying out esterification and rearrangement reaction on 2, 6, 6-trimethylcyclohexyl-2-ene-1, 4-diketone and an acylating agent to obtain the product, wherein the catalyst is selected from sulfuric acid, hydrochloric acid, phosphoric acid, fluoroboric acid, p-toluenesulfonic acid, benzenesulfonic acid, methanesulfonic acid, chloroacetic acid, BF3, BF3.OEt2, AlCl3, FeCl3, ZnCl2, TiCl4, SnCl2 and the like, and the cocatalyst is selected from nicotinic acid, 3-pyridylaldehyde, phenyl nicotinate, furoate nicotinate, 5-hydroxy-6-methyl nicotinic acid and 5-hydroxy-6-methyl ethyl nicotinate. The process has the advantages of easiness in industrialization, good selectivity, high product yield and the like.

This invention provides a composition with method of controlling and attracting noxious arthropods, and protecting plants from damage caused by noxious arthropods. The invention provides a noxious arthropod attractant composition that shows synergistic effects and comprises at least two types of compounds selected from the group consisting of p-anisaldehyde, benzaldehyde, ethyl nicotinate, geraniol, linalool, nerol, citronellol, o-anisaldehyde, β-farnesene, methyl anthranilate, methyl benzoate, o-aminoacetophenone, o-anisidine, methyl m-aminobenzoate, methyl o-toluate, eugenol, 3-phenylpropylaldehyde, cinnamaldehyde, eucalyptol, squalene and α-hexylcinnamaldehyde.

The invention discloses a preparation method of beta-nicotinamide mononucleotide and a purification method. The purification method of a furanose substrate intermediate material comprises the following steps: (1) extracting the furanose substrate intermediate material serving as a raw material by adopting a water phase and an oil phase, and collecting a water phase containing a compound shown in aformula I; and (2) extracting the water phase containing the compound shown in the formula I in the step (1) by adopting a phosphorylation auxiliary agent, and collecting a phosphorylation auxiliaryagent phase containing the compound shown in the formula I to obtain a purified furanose substrate intermediate material, wherein the raw material furanose substrate intermediate material is a mixed material containing the compound shown in the formula I, and R1 is one or more of acetyl, bromine, nicotinamide, ethyl nicotinate and butyl nicotinate. The preparation method of the beta-nicotinamide mononucleotide can effectively improve the total yield and purity, the reaction raw materials are cheap and easy to obtain, and the preparation process is simple and suitable for industrial production.

The invention provides a method for preparing tazarotene without copper iodide. Palladium catalysts and triphenylphosphine are added into specific organic solvents and stirred, replacement in nitrogenis performed, 4, 4-dimethyl thiochroman-6-radical-acetylene, 6-chloro-ethyl nicotinate and acid-binding agents are added to perform reaction. The method is environmentally friendly, the catalysts areeasily recycled, and waste water containing heavy metal is not generated. Compared with the prior art, the method is short in reaction time and reaction temperature. A product prepared by the methodis high in yield and purity and stable in quality.

The invention discloses a preparation method of a high-purity L-nicotine medical intermediate, which comprises the following steps: synthesis of myosmin: pumping dry xylene into a condensation reaction kettle, adding metal sodium and tert-butyl alcohol, heating, preserving heat, and cooling for later use; the method comprises the following steps: pumping xylene, ethyl nicotinate and N-vinylpyrrolidone into a reaction kettle, carrying out heat preservation, carrying out stirring until the solution is clear, and pumping the solution into a high position; dropwise adding the high-order reaction liquid into a condensation reaction kettle, heating after dropwise adding, and cooling for later use; adding concentrated hydrochloric acid and water into an acidolysis kettle, stirring and cooling, transferring a reaction solution in the condensation reaction kettle into the acidolysis kettle, transferring a layered lower water layer into a reflux kettle for reflux, transferring into a desolventizing kettle, transferring a desolventizing kettle bottom solution into a myosmin distillation kettle, and distilling off myosmin under reduced pressure; and preparing the L-nicotine. By adopting the preparation method of the high-purity L-nicotine medical intermediate, the high-purity L-nicotine is obtained, the consumption of acid, alkali and organic matters is reduced, and the cost is greatly reduced.

The invention discloses an after-finishing technology for home textile fabric based on shea butter, and belongs to the home textile fabric processing technologies. The after-finishing technology for home textile fabric based on shea butter is completed via the steps of preparation of oil phase, preparation of aqueous phase, preparation of nano-emulsion, preparation of finishing liquid, padding processing, washing and drying. The nano-emulsion is added into the finishing liquid, the nano-emulsion is prepared by using shea butter, and then the shea butter is combined with the textile fabric viathe after-finishing technology, so that when skin of a consumer is in contact with the textile fabric, the effect of moistening skin and preserving moisture is achieved; hyaluronic acid, butyl ethyl nicotinate and acetyl hydroxyproline are added, so that glossiness of the fabric is improved; meanwhile, a mite suppression agent is added, so that the mote suppression effect of the textile fabric isrealized; and due to addition of chitin, the fabric has the anti-microbial and bacteriostatic effects.

The invention relates to rheumatism expelling bath salt and a preparing method thereof. The rheumatism expelling bath salt comprises, by mass, 80-110 parts of anhydrous sodium sulfate, 2-8 parts of potassium chloride, 4-12 parts of sodium stearate, 15-25 parts of ethyl nicotinate, 30-40 parts of beta-lactose, 25-35 parts of sodium chloride, 10-19 parts of fat alkylamide propyl dimethyl amine oxide, 1.5-6.5 parts of kojic acid, 0.1-0.5 part of pigment, 2-5 parts of jasmine essence, 4-9 parts of carboxy methyl cellulose, 12-20 parts of Chinese starjasmine stem, 10-18 parts of loofah sponge and 8-15 parts of long-noded pit viper. The bath salt can be used for effectively removing dirt on the surface of the skin to make the skin become white, tender, smooth and rich in elasticity, meanwhile, the effect of expelling rheumatism is achieved, and after the bath salt is used for a long time, generation and relapses of rheumatism can be prevented effectively, and rheumatism can be effectively treated.

A mid-temperature electronic cigarette that heats ingredients to a temperature range between 125 and 145 degrees Fahrenheit. The temperature range is critical for a consistent cigarette-like taste, aroma, and physiological satisfaction. The ingredients can include tobacco extract, ethyl nicotinate, ethanol, nicotine and ethanol-based flavors, DMEA, but not propylene glycol (PG) or vegetable glycerin (VG). Due to the consistent temperature range, the mid-temperature electronic cigarette can consistently deliver 8-10 μg nicotine per puff, for at least 10 puffs, over 2-8 hours.

The invention provides a compound of formula (I): (I) wherein R is methyl or ethyl. The invention also provides a process for the preparation of the compound. The invention further provides a method for increasing cell NAD⁺ production or improving mitochondrial densities in a cell, wherein the method comprises administering to the cell a compound or salt of the invention.

A method for synthesis of 4-OH substituted anabaseine derivative which is used as an α₇ receptor agonist is revealed. A nucleophilic substitution reaction of δ-valerolactam with ethyl nicotinate is carried out to get an intermediate product. Then heat the intermediate product under reflux with concentrated hydrochloric acid to get a cyclized product-anabaseine. Next anabaseine and 4-hydroxyethoxy-2-methoxybenzaldehyde are reacted under concentrated hydrochloric acid catalysis to get a 4-OH anabaseine derivative 3-[(4-Hydroxyethoxy-2-methoxy)-benzylidene]anabaseine. The 4-OH anabaseine derivative is synthesized and prepared easily by the present invention. Not only the steps for synthesis are simplified, the yield is as high as 60%. The product can be mass-produced.

The invention provides an iridium (III) complex. A 2-phenylethyl isonicotinate derivative is used as the main ligand, and 3,6-di-tert-butyl -9-(4-(4,5)-dimethyl-2-(pyrid-2-yl)-1H-imidazol-1-yl) butyl)-9H-carbazole is used as the auxiliary ligand. The iridium (III) complex has good light stability, large Stokes shift, high luminous efficiency and aggregation-induced emission property, and can be applied to the field of cell imaging.

The invention provides a synthesis method of beta-nicotinamide mononucleotide. The synthesis method of the beta-nicotinamide mononucleotide comprises the following steps: S1, condensation reaction: adding ethyl nicotinate, tetraacetylribose and a solvent A into a reaction kettle, performing stirring and dissolving at room temperature, dropwise adding a solution of a catalyst A, carrying out condensation reaction at 50 DEG C for 1 hour, cooling to room temperature after the reaction is finished, adding ethanol for quenching reaction, and removing the solvent under reduced pressure, and obtaining triacetyl nucleoside containing ethyl nicotinate; and S2, deacetylation: dissolving the ethyl nicotinate triacetyl nucleoside obtained in the step S1 into ethanol, and dropwise adding organic alkaliat 0 DEG C. The synthesis method of beta-nicotinamide mononucleotide provided by the invention has the advantages that two steps of phosphorylation and ammonolysis are integrated into one step, leakage of dangerous materials such as phosphorus oxychloride and ammonia gas and the like is avoided, the operation is safe and reliable, and the production cost is greatly reduced.